AM2201 6-hydroxyindole metabolite
- $117 - $452
- Product name: AM2201 6-hydroxyindole metabolite
- CAS: 1427521-35-4
- MF: C24H22FNO2
- MW: 375.44
- EINECS:
- MDL Number:
- Synonyms:AM2201 6-hydroxyindole metabolite;[1-(5-fluoropentyl)-6-hydroxyindol-3-yl]-naphthalen-1-ylmethanone;Methanone, [1-(5-fluoropentyl)-6-hydroxy-1H-indol-3-yl]-1-naphthalenyl-
3 prices
Selected condition:
Brand
- AK Scientific
- Cayman Chemical
Package
- 1mg
- 5mg
- ManufacturerAK Scientific
- Product number0528EC
- Product descriptionAM22016-hydroxyindolemetabolite
- Packaging1mg
- Price$228
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number11192
- Product descriptionAM2201 6-hydroxyindole metabolite ≥98%
- Packaging1mg
- Price$117
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number11192
- Product descriptionAM2201 6-hydroxyindole metabolite ≥98%
- Packaging5mg
- Price$452
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 0528EC | AM22016-hydroxyindolemetabolite | 1mg | $228 | 2021-12-16 | Buy |
Cayman Chemical | 11192 | AM2201 6-hydroxyindole metabolite ≥98% | 1mg | $117 | 2024-03-01 | Buy |
Cayman Chemical | 11192 | AM2201 6-hydroxyindole metabolite ≥98% | 5mg | $452 | 2024-03-01 | Buy |
Properties
Boiling point :597.7±40.0 °C(Predicted)
Density :1.19±0.1 g/cm3(Predicted)
solubility :DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml; Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml
form :A crystalline solid
pka :9.74±0.40(Predicted)
Density :1.19±0.1 g/cm3(Predicted)
solubility :DMF: 20 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml; Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml
form :A crystalline solid
pka :9.74±0.40(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|